Biomarkers and testing in pathology
Although pathology is still the gold standard in diagnosis of tumor for patients in uropathology, many clinicians want to improve treatment options and try to tailor personalized treatments. This is of course depending not only on the available treatment options, but also on the somatic or germcell background of the patient and his tumor.
Authors
- Eva Compérat
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- Current Opinion in Urology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1097/mou.0000000000001363
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00